Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beyond the efficacy of transcranial magnetic stimulation in peripartum depression: A systematic review exploring perinatal safety for newborns.
Miuli A, Pettorruso M, Stefanelli G, Giovannetti G, Cavallotto C, Susini O, Pasino A, Bubbico G, De Risio L, Petta GD, Sensi SL, D'Antonio F, Martinotti G. Miuli A, et al. Among authors: cavallotto c. Psychiatry Res. 2023 Aug;326:115251. doi: 10.1016/j.psychres.2023.115251. Epub 2023 May 22. Psychiatry Res. 2023. PMID: 37270864 Review.
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G, Dell'Osso B, Di Lorenzo G, Maina G, Bertolino A, Clerici M, Barlati S, Rosso G, Di Nicola M, Marcatili M, d'Andrea G, Cavallotto C, Chiappini S, De Filippis S, Nicolò G, De Fazio P, Andriola I, Zanardi R, Nucifora D, Di Mauro S, Bassetti R, Pettorruso M, McIntyre RS, Sensi SL, di Giannantonio M, Vita A; REAL-ESK Study Group. Martinotti G, et al. Among authors: cavallotto c. Bipolar Disord. 2023 May;25(3):233-244. doi: 10.1111/bdi.13296. Epub 2023 Jan 18. Bipolar Disord. 2023. PMID: 36636839 Free article.
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine.
Pettorruso M, d'Andrea G, Di Carlo F, De Risio L, Zoratto F, Miuli A, Benatti B, Vismara M, Pompili E, Nicolò G, Niolu C, Siracusano A, Sensi SS, Dell'Osso B, Di Lorenzo G, Martinotti G; ReModula Study Group. Pettorruso M, et al. Brain Stimul. 2023 Jul-Aug;16(4):1041-1043. doi: 10.1016/j.brs.2023.06.003. Epub 2023 Jun 17. Brain Stimul. 2023. PMID: 37331507 Free article. No abstract available.
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances.
Chiappini S, Vaccaro G, Mosca A, Miuli A, Stigliano G, Stefanelli G, Giovannetti G, Carullo R, d'Andrea G, Di Carlo F, Cavallotto C, Pettorruso M, Di Petta G, Corkery JM, Guirguis A, Stair JL, Martinotti G, Fazel S, Schifano F. Chiappini S, et al. Among authors: cavallotto c. Neurosci Biobehav Rev. 2024 May 10;162:105691. doi: 10.1016/j.neubiorev.2024.105691. Online ahead of print. Neurosci Biobehav Rev. 2024. PMID: 38733894 Review.
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study.
Chiappini S, Cavallotto C, Mosca A, Di Carlo F, Piro T, Giovannetti G, Pasino A, Vicinelli M, Lorenzini C, Di Paolo M, Pepe M, Di Nicola M, Ricci V, Pettorruso M, Martinotti G. Chiappini S, et al. Among authors: cavallotto c. Pharmaceuticals (Basel). 2024 Apr 21;17(4):535. doi: 10.3390/ph17040535. Pharmaceuticals (Basel). 2024. PMID: 38675495 Free PMC article.
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation.
Cavallotto C, Chiappini S, Mosca A, d'Andrea G, Di Carlo F, Piro T, Susini O, Stefanelli G, Di Cesare A, Ricci V, Pepe M, Dattoli L, Di Nicola M, Pettorruso M, Martinotti G. Cavallotto C, et al. J Clin Med. 2024 Apr 11;13(8):2206. doi: 10.3390/jcm13082206. J Clin Med. 2024. PMID: 38673478 Free PMC article.
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial.
Ostuzzi G, Gastaldon C, Tettamanti M, Cartabia M, Monti I, Aguglia A, Aguglia E, Bartoli F, Callegari C, Canozzi A, Carbone EA, Carrà G, Caruso R, Cavallotti S, Chiappini S, Colasante F, Compri B, D'Agostino A, De Fazio P, de Filippis R, Gari M, Ielmini M, Ingrosso G, Mammarella S, Martinotti G, Rodolico A, Roncone R, Sterzi E, Tarsitani L, Tiberto E, Todini L, Amaddeo F, D'Avanzo B; VESPA Study Group; Barbato A, Barbui C. Ostuzzi G, et al. EClinicalMedicine. 2024 Feb 15;69:102491. doi: 10.1016/j.eclinm.2024.102491. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384338 Free PMC article.
Corrigendum to "Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine" [Brain Stimul 16 (2023)].
Pettorruso M, d'Andrea G, Di Carlo F, De Risio L, Zoratto F, Miuli A, Benatti B, Vismara M, Pompili E, Nicolò G, Niolu C, Siracusano A, Sensi SL, Dell'Osso B, Di Lorenzo G, Martinotti G; ReModula Study Group. Pettorruso M, et al. Brain Stimul. 2023 Sep-Oct;16(5):1361. doi: 10.1016/j.brs.2023.09.003. Epub 2023 Sep 14. Brain Stimul. 2023. PMID: 37716051 Free article. No abstract available.
Quality of life and psychopathology in candidates to bariatric surgery: relationship with BMI class.
Martinelli V, Cappa A, Zugnoni M, Cappello S, Masi S, Klersy C, Pellegrino E, Muggia C, Cavallotto C, Politi P, Bruno F, Mineo N, Peri A, Lobascio F, Chiappedi M, Dakanalis A, Pietrabissa A, Caccialanza R. Martinelli V, et al. Among authors: cavallotto c. Eat Weight Disord. 2021 Mar;26(2):703-707. doi: 10.1007/s40519-020-00881-z. Epub 2020 Mar 7. Eat Weight Disord. 2021. PMID: 32146595